Outbreak of viral parotiditis in a school in Bizkaia, Spain, in 2006;Brote de parotiditis vírica en un colegio de Bizkaia en 2006

Revista Espanola de Salud Publica

Volumn 81, Issue 1, 2007, Pages 33-42

  Ortuondo, Eduardo Millán ^a,d   Sancristóbal, Itxaso González ^b   Soria, Leyre López ^a   Mayo, Juan Emilio Echevarría ^c   Laiz, Visitación De Castro ^b   Agirre, Nerea Muniozguren ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b Unidad de Vigilancia Epidemiológica de Bizkaia   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Dept de Sanidad   (Spain)

Author keywords

Epidemiology; Mumps; Mumps virus; Vaccination

Indexed keywords

EID: 34249659612     PISSN: 11355727     EISSN: 16969820     Source Type: Journal    
DOI: 10.1590/s1135-57272007000100005     Document Type: Article

References (29)

1. Plotkin SA. Mumps Vaccine. En: Plotkin SA, Orenstein WA, editores. Vaccines. Philadelphia: Elsevier;2003.p.441-69
2. a ed. Washington: OPS;2001.p.499-502
3. Anderson RM, May RM. Modern vaccines: immunization and herd immunity. Lancet 1990;335:641-5
4. Gay N, Miller E, Hesketh P, Morgan-Capner P, Ramsay M, Cohen B et al. Mumps surveillance in England and Wales support introduction of two doses vaccination schedule. Commun Dis Rep Rev 1997;7:21-6
5. Perry KR, Brown DW, Parry JV, Panday S, Pipkin C, Richards A. Detection of measles, mumps and rubella antibodies using antibody capture immunoassay. J Med Virol 1993;40:235-40
6. Uchida K, Shinohara M, Shimada S, Segawa Y, Doi R, Gotoh A et al. Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR. J Med Vir 2005;75:470-4
7. a ed. Philadelphia: Lippincot, Williams and Wilkins; 2001.p.1381-1400
8. Vandermeulen C, Roelants M, Vermoere M, Roseew K, Goubau P, Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 2004;22:2713-6
9. Mitchell LA, Tingle AJ, Decarie D, Lajeunesse C. Serologic responses to measles, mumps and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR. Can J Public Health 1998;89:325-8
10. Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner P, Brown D et al. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 2002;20:1134-40
11. Davidkin I, Valle M, Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine year follow-up. Vaccine 1995;13:1617-22
12. Centers for Disease Control and Prevention. Measles, mumps, and rubella-vaccine use and strategies for measles, rubella, and congenital rubella syndrome elimination and mumps control: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998; 47 (RR-8): 1-57
13. Anderson R, May R. Immunization and herd immunity. Lancet 1990;335:641-5
14. Gupta RK, Best J, Mac Mahon E. Mumps and the UK epidemic 2005. BMJ 2005;330:1132-5
15. Visser LE, Gonzáles Pérez LC, Ramos Tejera J, Berjón Barrientos AC, Vergara Guerrero Y, Martines navarro F. An outbreak of mumps in the province of Leon Spain 1995-1996. Euro Surveill 1998;3:14-8
16. Public Health Agency of Canada. Outbreak of mumps among young adults-Vancouver, British Columbia.[citado 15 de nov. 1997]. http://www.phacaspc.gc.ca/publicat/ccdr-rmtc/97vol23/dr2322ea.html
17. Centers for Disease Control and Prevention. Update: Multistate outbreak of mumps-United States, January 1-May 2,2006.MMWR Morb Mortal Wkly Rep 2006;55:1-5
18. Chamot E, Toscani L, Egger P, German D, Bourquin C. Estimation of the efficacy of the strains of mumps vaccines during an epidemic of mumps in the Geneva Canton (Switzerland). Rev Epidemiol Sante Publique 1998;46:100-7
19. Limón Mora J, Molina Lopez T, Domínguez Camacho JC. Community effectiveness of vaccines against infectious parotiditis (mumps). Report of cases. Rev Esp Salud Pública 1999;73:455-64
20. Gonçalves G, De Araújo A, Monteiro Cardoso ML. Outbreak of mumps associated with poor vaccine efficacy-Oporto Portugal 1996. Euro Surveill 1998;3:119-21
21. Word Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec. 2001;76:345-56
22. Poggio GP, Rodríguez C, Cisterna D, Freire MC, Cello J. Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J Clin Microbiol 2000;38(1):274-278
23. Palacios G, Jabado O, Cisterna D, de Ory F, Renwick N, Echevarria JE et al. Molecular identification of mumps virus genotypes from clinical simples: Standarized method of analysis. J Clin Microbiol 2005;43(4):1869-1878
24. Richard JL, Zwahlen M, Feuz M, Matter HC. Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 20000: a case-cohort study. Eur J Epidemiol 2003;18:569-77
25. Harling R, White JM, Ramsay ME, Macsween KF, Van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2004;23:4070-74
26. Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure?. Vaccine 2004;22:2713-6
27. De los Ríos Martín R, García Marín N, Sanz Moreno JC, Ballester Orcal E. Parotiditis en un área urbana de la Comunidad de Madrid. Estado vacunal, diagnóstico y medidas de intervención Aten Primaria 2001;28:10-16
28. Centers of Disease Control and Prevention. Mumps epidemic-Iowa,2006.MMWR Morb Mortal Wkly Rep 2006;55:366-68
29. Šantak M, Ko‰utiç-Gulija T, Te‰oviç G, Ljubin-Sternak S, Gjenero-Margan I, Betica-Radiç L, Forãiç D. Mumps virus strains isolated in Croatia in 1998 and 2005: Genotyping and putative antigenic relatedness to vaccine strains. J Med Virol. 2006;78:638-43